Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
Objective: to study the sensitivity of gastrointestinal stromal tumors (GISTs) to the topoisomerases type II inhibitors and ability of imatinib to enhance GISTs sensitivity to the chemotherapeutic drugs indicated above.Subjects and Methods. We studied the sensitivity of gastrointestinal stromal tumo...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2015-06-01
|
Series: | Успехи молекулярной онкологии |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/7 |
_version_ | 1797759378875482112 |
---|---|
author | S. V. Boichuk A. R. Galembikova B. R. Ramazanov A. Duensing |
author_facet | S. V. Boichuk A. R. Galembikova B. R. Ramazanov A. Duensing |
author_sort | S. V. Boichuk |
collection | DOAJ |
description | Objective: to study the sensitivity of gastrointestinal stromal tumors (GISTs) to the topoisomerases type II inhibitors and ability of imatinib to enhance GISTs sensitivity to the chemotherapeutic drugs indicated above.Subjects and Methods. We studied the sensitivity of gastrointestinal stromal tumors (GISTs) to the topoisomerases II inhibitors and ability of imatinib to enhance GISTs sensitivity to these chemotherapeutic agents. The expression of DNA damage and repair (DDR) markers was examined by western-blotting. Cleaved forms of poly (ADP-rybose) polymerase and caspase-3 were served as an apoptotic markers measured by western blotting. Amount of apoptotic cells was counted by flow cytometry analysis by using a propidium iodide DNA staining procedure and counting the numbers of hypodiploid cells.Results. We observed the sensitivity of GISTs to topoisomerase II inhibitors – doxorubicine and etoposide inducing DNA double-strand breaks and apoptotic cell death. Imatinib enhances GISTs sensitivity to topoisomerase II inhibitors. This might be due to reduced ability of GISTs to repair DNA damage by homologous recombination. Imatinib-induced reduction of Rad51 recombinase might be due to increased proteasome-dependent degradation.Conclusion. GIST cells are sensitive to topoisomerase II inhibitors (etoposide and doxorubicin) in vitro. Imatinib enhances GISTs sensitivity to the chemotherapeutic agents indicated above. |
first_indexed | 2024-03-12T18:43:35Z |
format | Article |
id | doaj.art-38a4a30fa0504f2c97c29df7657fb45c |
institution | Directory Open Access Journal |
issn | 2313-805X 2413-3787 |
language | Russian |
last_indexed | 2024-03-12T18:43:35Z |
publishDate | 2015-06-01 |
publisher | ABV-press |
record_format | Article |
series | Успехи молекулярной онкологии |
spelling | doaj.art-38a4a30fa0504f2c97c29df7657fb45c2023-08-02T07:48:04ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872015-06-012107608110.17650/2313-805X.2015.2.1.076-0817Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitorsS. V. Boichuk0A. R. Galembikova1B. R. Ramazanov2A. Duensing3ГБОУ ВПО «Казанский государственный медицинский университет» Минздрава России; Раковый центр Университета г. ПиттсбургаГБОУ ВПО «Казанский государственный медицинский университет» Минздрава РоссииГБОУ ВПО «Казанский государственный медицинский университет» Минздрава РоссииРаковый центр Университета г. ПиттсбургаObjective: to study the sensitivity of gastrointestinal stromal tumors (GISTs) to the topoisomerases type II inhibitors and ability of imatinib to enhance GISTs sensitivity to the chemotherapeutic drugs indicated above.Subjects and Methods. We studied the sensitivity of gastrointestinal stromal tumors (GISTs) to the topoisomerases II inhibitors and ability of imatinib to enhance GISTs sensitivity to these chemotherapeutic agents. The expression of DNA damage and repair (DDR) markers was examined by western-blotting. Cleaved forms of poly (ADP-rybose) polymerase and caspase-3 were served as an apoptotic markers measured by western blotting. Amount of apoptotic cells was counted by flow cytometry analysis by using a propidium iodide DNA staining procedure and counting the numbers of hypodiploid cells.Results. We observed the sensitivity of GISTs to topoisomerase II inhibitors – doxorubicine and etoposide inducing DNA double-strand breaks and apoptotic cell death. Imatinib enhances GISTs sensitivity to topoisomerase II inhibitors. This might be due to reduced ability of GISTs to repair DNA damage by homologous recombination. Imatinib-induced reduction of Rad51 recombinase might be due to increased proteasome-dependent degradation.Conclusion. GIST cells are sensitive to topoisomerase II inhibitors (etoposide and doxorubicin) in vitro. Imatinib enhances GISTs sensitivity to the chemotherapeutic agents indicated above.https://umo.abvpress.ru/jour/article/view/7гастроинтестинальные стромальные опухолииматинибхимиопрепаратыапоптозповреждение и репарация днкрекомбиназа rad51 |
spellingShingle | S. V. Boichuk A. R. Galembikova B. R. Ramazanov A. Duensing Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors Успехи молекулярной онкологии гастроинтестинальные стромальные опухоли иматиниб химиопрепараты апоптоз повреждение и репарация днк рекомбиназа rad51 |
title | Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors |
title_full | Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors |
title_fullStr | Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors |
title_full_unstemmed | Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors |
title_short | Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors |
title_sort | imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase ii inhibitors |
topic | гастроинтестинальные стромальные опухоли иматиниб химиопрепараты апоптоз повреждение и репарация днк рекомбиназа rad51 |
url | https://umo.abvpress.ru/jour/article/view/7 |
work_keys_str_mv | AT svboichuk imatinibenchancesthesensitivityofgastrointestinalstromaltumorstotopoisomeraseiiinhibitors AT argalembikova imatinibenchancesthesensitivityofgastrointestinalstromaltumorstotopoisomeraseiiinhibitors AT brramazanov imatinibenchancesthesensitivityofgastrointestinalstromaltumorstotopoisomeraseiiinhibitors AT aduensing imatinibenchancesthesensitivityofgastrointestinalstromaltumorstotopoisomeraseiiinhibitors |